Seven blood protein biomarkers are currently being used in ongoing amyotrophic lateral sclerosis trials,14 but only one, high-sensitivity cardiac troponin T (hs-cTnT),105 has promising potential as a diagnostic. Here, TNNT2 is linked to amyotrophic lateral sclerosis.